SCHEMBL27831709

SCHEMBL27831709

COC(=O)c1ccccc1Oc1ccc(N2CCN(Cc3cc(OCCCN(C)C)ccc3Br)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ FAAH O00519 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MMP1 P03956 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ ADAM17 P78536 1/20 0.40
▸ BCL2 P10415 1/20 0.40
▸ CACNA1H O95180 1/20 0.40
▸ CACNA1B Q00975 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ABCB1 P08183 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958106 0.92 BCL2 (0.44) FAAHALDH1A1BCL2SMN1; SMN2KDM4E
SCHEMBL1957122 0.88 BCL2 (0.43) FAAHBCL2
SCHEMBL27831767 0.88 KMT2A (0.47) CYP2C9CYP2C19KMT2AALDH1A1MEN1
SCHEMBL27850404 0.86 BCL2 (0.51) CYP2C9CYP2C19CYP1A2CYP3A4BCL2
SCHEMBL27850269 0.85 KMT2A (0.48) CYP2C9CYP2C19KMT2ACYP1A2CYP3A4
SCHEMBL1959132 0.80 KMT2A (0.44) KMT2AFAAHALDH1A1MEN1MAPT
SCHEMBL1957648 0.80 BCL2 (0.46) BCL2TSHRKDM4E
SCHEMBL1957509 0.79 BCL2 (0.56) BCL2
SCHEMBL28791299 0.78 BCL2 (0.49) BCL2
SCHEMBL1958252 0.75 BCL2 (0.44) KMT2AALDH1A1LMNAMMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102307872-A BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBOTT LAB 2012-01-04 — — CN disclosed
Send feedback